Neural cell state modulation by <i>PARK2</i> and dopaminergic neuroprotection by small molecule Parkin agonism
Yongxing Gong(Memorial Sloan Kettering Cancer Center), Xiqun Chen(Harvard University), Jackson G. Schumacher(Boston College), Timothy A. Chan(Cleveland Clinic), Prerana Bangalore Parthasarathy(Cleveland Clinic), Armin Bayati(Montreal Neurological Institute and Hospital), M. A. Schwarzschild(Harvard University), Yuhang Zhao(Zhejiang International Studies University), Fang Zhou(Harvard University), Laura A. Volpicelli-Daley(German Center for Neurodegenerative Diseases), Shovan Dutta(Cleveland Clinic), Wen Luo(Montreal Neurological Institute and Hospital), Chienwen Su(Harvard University), Vijay Singh(University of Alabama at Birmingham), Thomas M. Durcan(Montreal Neurological Institute and Hospital), Tyler Alban(Cleveland Clinic), Vladimir Makarov(Cleveland Clinic), Jennifer Johnston(Mill Valley Public Library)
Cited by 0
Related Papers
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
|Science|2016|3.1k
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
|Annals of Oncology|2018|2.9k
Aggresomes: A Cellular Response to Misfolded Proteins
|The Journal of Cell Biology|1998|2.1k